SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-22-004728
Filing Date
2022-06-30
Accepted
2022-06-30 16:30:10
Documents
4
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY phio_def14a-080922.htm DEF 14A 201443
2 GRAPHIC a1.jpg GRAPHIC 3114
3 GRAPHIC image1.jpg GRAPHIC 144382
4 GRAPHIC image2.jpg GRAPHIC 114133
  Complete submission text file 0001683168-22-004728.txt   563207
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36304 | Film No.: 221058376
SIC: 2834 Pharmaceutical Preparations